AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination
The treatment targets patients whose cancer progressed following prior EGFR-targeted treatment
Key takeaways
- Category: Company.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.












